Track topics on Twitter Track topics that are important to you
Forbes seeks to be a leader in delivering scientifically proven health benefits to consumers through innovative products derived from nature. The Company believes that consumers are increasingly looking to the prevention of illness as much as to its cure. The Company's strategy is to leverage its core technologies through strategic partnerships and business associations to deliver functional food and pharmaceutical products focused on the prevention and treatment of disease.
Forbes currently focuses its product development efforts on plant sterols derived from pulping and agricultural by-products. Plant Sterols have long been known for their cholesterol-lowering properties. Forbes believes it has made important technological advances in these areas and offers significant commercial opportunities in three distinct markets:
Functional Foods: Phytrol™ is a cholesterol-lowering ingredient for use in functional foods and, potentially, in dietary supplements and over-the-counter products.
Prescription Pharmaceuticals: Forbes is developing FM-VP4, a prescription therapeutic, for the prevention and treatment of cardiovascular disease through the reduction of cholesterol and, potentially, atherosclerotic plaque.
Pharmaceutical Steroids: Forbes has developed technology to produce steroid intermediates Androstenedione (AD) and Androstadienedione (ADD) which are used in the manufacture of various steroid-based pharmaceutical products such as birth control pills and anti-inflammatories.
Forbes is pursuing a common strategy in each of these areas:
Competitive advantage through technology: Proprietary technologies provide Forbes with product or process advantages over existing competition.
Targeting significant markets: Forbes focuses the development of its technology within markets that offer significant potential. Each of its three target markets currently represents a multi-billion dollar global market.
Commercialization through strategic partnerships and business associations: The Company believes that leveraging its technology through strategic partnerships and business associations will accelerate commercialization and maximize the chances of success. Forbes Has a Joint venture with Chusei (USA) Inc. of Pasadena, Texas to form Phyto-Source LP, a Texas Limited Partnership. Through this joint venture, Forbes and Chusei are building one of the worlds largest dedicated wood sterol manufacturing plants with and annuall capacity of 1,000 metric tonnes. Forbes also has entered into a Manufacturing Agreement with FERMIC, S.A. DE C.V. in Mexico City to produce fine chemical intermediates Androstenedione (AD) and Androstadienedione (ADD) on the Company's behalf for sale in international markets.
Suite 200 - 750 West Pender Street
Phone: (604) 689-5899
VANCOUVER, BRITISH COLUMBIA - September 1, 2017 (Investorideas.com Newswire) Standard Graphite Corp. (TSX VENTURE:SGH) (the "Company") is pleased to announce that it has entered into a share purchase ...
(Reuters) - Amazon.com Inc Chief Executive Jeff Bezos has unseated fellow tech billionaire Bill Gates as the richest person in the world, profiting from the e-commerce company's meteoric stock rise t...
Smithsburg, Maryland (PRWEB) September 07, 2017 MEDI+SIGN announces the recent designation of ResponderSync Partner by Rauland-Borg,...
Here are all the stories we published yesterday.
California officials are being asked to review the requirement that massive, printed books be sent out to people who enroll for Medi-Cal. Outlets report on other Medicaid news out of South Carolina an...
Here are all the stories we published yesterday.
LabCorp, a global life sciences company, has been named to Forbes’ 2017 ranking of “The World’s Most Innovative Companies.” “Innovation in guiding patient care is what we do at LabCorp, so b...
Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has been included in Forbes magazine’s America’s Best Employ...
Denti-Care Denti-Rinse 2 % Neutral Sodium Fluoride Oral Rinse Berry
Denti-Care Denti-Rinse 2 % Neutral Sodium Fluoride Oral Rinse Mint
Denti-Care Denti-Freeze Topical Anesthetic Gel Strawberry
Denti-Care Denti-Freeze Topical Anesthetic Gel Raspberry
Mental disorders (MeDi) and suicide attempts (SA) are influenced by environmental and genetic factors. Genetic polymorphism studies have identified some candidate genes for suicidal behaviour in peopl...
MEDI-570 is a fully human afucosylated monoclonal antibody (MAb) against Inducible T-cell costimulator (ICOS), highly expressed on CD4+ T follicular helper (TFH) cells. Effects of MEDI-570 were evalua...
Evidence from epidemiologic studies suggests a relation between the Mediterranean diet (MeDi) and cognitive function, but results are inconsistent. Prior reviews have not provided pooled data from met...
Little is known about the importance of the Mediterranean Diet (MeDi) and dietary intake as environmental neuroprotective factors in Huntington's disease (HD); so, we evaluated and analyzed the preval...
A ready-made dry medium method for <em>Escherichia coli</em> and coliform count, the Medi•Ca EC method, wascompared with the most probable number (MPN) method using Brilliant Green Lacto...
The purpose of this study is to evaluate the safety and tolerability of MEDI-570 in adult subjects with moderately to severely active systemic lupus erythematosus (SLE).
The primary objective of this study is to evaluate the safety and tolerability of intravenously administered MEDI-545 compared with placebo, over a dose escalation range of 0.3-30 mg/kg, i...
To assess the safety of escalating dose levels of MEDI-507 in pediatric stem cell and bone marrow allograft recipients who have at least Grade II GvHD.
To compare disease activity, as measured by PASI score, of three MEDI-507 dosing (injection)regimens vs. placebo.
A Phase I studyto evaluate the safety and tolerability of escalating subcutaneous (SC) doses of MEDI-528 in to healthy adult volunteers.
Forbes Insights (www.forbes.com/forbesinsights) is the strategic research practice of Forbes Media, publisher of Forbes magazine and Forbes.com. Taking advantage of a proprietary ...
Forbes Media LLC, publisher of Forbes magazine and forbes.com, is an authoritative source of news and information on business, investing, technology, entrepreneurship, leadership ...
Medi tech Group, having 2 daughter companies, MD and CMS, founded in 1998, is a group dedicated to provide state-of-the-art products with top-ranking quality and upstanding reputation. As a good provi...
Forbes seeks to be a leader in delivering scientifically proven health benefits to consumers through innovative products derived from nature. The Company believes that consumers are increasingly looki...
Medi-Span is the leading provider of drug information for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer author...
We have published hundreds of Forbes Medi-Tech news stories on BioPortfolio along with dozens of Forbes Medi-Tech Clinical Trials and PubMed Articles about Forbes Medi-Tech for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Forbes Medi-Tech Companies in our database. You can also find out about relevant Forbes Medi-Tech Drugs and Medications on this site too.
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...